Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2

• المؤلفون الرئيسيون: Xiang Tong (مؤلف), Shijie Zhang (مؤلف), Dongguang Wang (مؤلف), Li Zhang (مؤلف), Jizheng Huang (مؤلف), Tianli Zhang (مؤلف), Hong Fan (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Pulmonary fibrosis (PF) is a chronic and progressive process of tissue repair. Azithromycin (AZM) may be beneficial for the treatment of PF because AZM has anti-inflammatory and immune regulatory roles and inhibits remodeling, but the mechanism is not entirely clear. In this study, we established a...